Psilocybin‑assisted therapy and HIV‑related shame
As a proposed mediator between stigma-related stressors and negative mental health outcomes, HIV-related shame has been predictive of increased rates of substance use and difficulties
As a proposed mediator between stigma-related stressors and negative mental health outcomes, HIV-related shame has been predictive of increased rates of substance use and difficulties
Abstract A number of organizations have developed or are developing psychedelic integration groups, held in person or online. In parallel, there have been calls to
ABSTRACT Growing research exploring the utility of psychedelic substances suggests that they not only hold promise for clinical practice but may enhance mental health
ABSTRACT Background In psychedelic therapy, the importance of set and setting is a fundamental but under-researched assumption. The aim of this study is to
Background: The psychedelic 5-MeO-DMT has shown clinical potential due to its short duration and ability to induce mystical experiences. However, a phenomenon known as “reactivations”
ABSTRACT Background: Psilocybin therapy has shown promise as a rapid-acting treatment for depression, anxiety, and demoralization in patients with serious medical illness (e.g., cancer)
Background: Recent years have seen a resurgence of research on the potential of psychedelic substances to treat addictive and mood disorders. Historically and contemporarily, psychedelic
©2023 Unlimited Sciences. All rights reserved.
Our newsletter is meant to provide you with the latest news in psychedelic research, inform you about our work, and inspire you with compelling stories from all over the world about the power of psychedelics.